20/20 GeneSystems Inc
This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer.
01/26/2018
20/20 GeneSystems, Inc. finalized its first equity crowdfunding campaign this week with gross proceeds of $1.07 million, the maximum amount permitted under current SEC rules pursuant to Regulation CF. In so doing, the company became only the second medical technology firm to reach this maximum. 20/20 is now listed as one of the "Top 20 Regulation Crowdfunding Campaigns of All Time" by Crowdfund Capital Advisors. The campaign was posted on First Democracy VC, a joint venture between Indiegogo and MicroVentures...
https://finance.yahoo.com/news/20-20-closes-record-equity-135200954.html
10/31/2017
Our CEO was recently interviewed on ForbesBooks Radio. Please listen here...
http://2020gene.com/2020-ceo-jonathan-cohen-on-forbes-radio
20/20 CEO Jonathan Cohen on Forbes Radio | 2020 Gene Systems 20/20 CEO Jonathan Cohen on Forbes Radio by allsaints | Oct 31, 2017 | News | Our CEO was recently featured on Forbes Radio. Please listen here: http://2020gene.com/wp-content/uploads/2017/10/Jonathan-Cohen-20_20-GeneSystems-SEG1.mp3http://2020gene.com/wp-content/uploads/2017/10/Jonathan-Cohen-20_...
Click here to claim your Sponsored Listing.
Category
Contact the practice
Website
Address
15810 Gaither Drive, Ste 235
Gaithersburg, MD
20877
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |